throbber

`
`NIH) National Library of Medicine
`
`National Centerfor BiotechnologyInformation
`
`PublMedeo
`
`“pulmonary arterial hypertension" AND “clinical trial"
`
`Advanced Create alert Create RSS
`
`
`
`User Guide
`
`Save
`
`Email
`
`Send to
`
`Sorted by: Best match
`
`Display options 2
`
`113 results
`
`Page
`
`of 12 » »
`
`Medical therapeutics for pulmonaryarterial hypertension: from basic science
`and clinical trial design to evidence-based medicine.
`Sulica R, Poon M.
`
`Expert Rev Cardiovasc Ther. 2005 Mar:3(2):347-60. doi: 10.1586/14779072.3.2.347.
`PMID: 15853607
`Review.
`
`L 1
`
`Cite
`
`Share
`
`Left untreated, pulmonary arterial hypertension results in right-ventricular failure and death. There has
`
`been dramatic progress in the treatment of pulmonary arterial hypertension during recent years. A
`remarkable number of randomized-co...
`
`Bosentan therapy for pulmonary arterial hypertension.
`Rubin LJ, Badesch DB, Barst RJ, Galie N. Black CM, Keogh A, Pulide T, Frost A, Roux 5, Leconte|,
`
`Cite
`
`Landzberg M, Simonneau G.
`
`Share
`
`N Engl J Med. 2002 Mar 21:346(12):896-903. dor: 10.1056/NEIMoa012212.
`PMID: 11907289
`Free article.
`Clinical Trial.
`
`Bosentan also improved the Borg dyspnea index and WHO functional class and increased the time to
`
`clinical worsening. CONCLUSIONS: The endothelin-receptor antagonist bosentan is beneficial in patients
`
`with pulmonary arterial hypertension and is well tol...
`
`My Nee! FILTERS
`
`RESULTS BY YEAR
`
`—-
`1970
`
`2006
`
`TEXT AVAILABILITY
`
`[] Abstract
`
`[] Free full text
`
`[| Full text
`
`ARTICLE ATTRIBUTE
`
`[_] Associated data
`
`ARTICLE TYPE
`
`[| Books and Documents
`
`End points and clinical trial designs in pulmonary arterial hypertension:
`clinical and regulatory perspectives.
`[| Clinical Trial
`Cite
`Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Hawarth 5G, Frost AE, Torbicki A.
`J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):48S-55S.doi: 10.1016/jjacc.2004.02.010.—_Liquidia's Exhibit 1118
`[_] Meta-Analysis
`Share
`PMID: 15194178
`Free article.
`Review.
`Page 1
`ee ee er Pe egeaee eeae eeoe
`
`— Pandamived Cantrolled
`
`Liquidia's Exhibit 1118
`Page 1
`
`

`

`Page 1 of
`12
`
`113 results
`1 Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-
`based medicine.
`Sulica R, Poon M.
`Expert Rev Cardiovasc Ther. 2005 Mar;3(2):347-60. doi: 10.1586/14779072.3.2.347.
`PMID: 15853607 Review.
`
`2 Bosentan therapy for pulmonary arterial hypertension.
`Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G.
`N Engl J Med. 2002 Mar 21;346(12):896-903. doi: 10.1056/NEJMoa012212.
`PMID: 11907289 Free article. Clinical Trial.
`
`3 End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives.
`Hoeper MM, Oudiz RJ, Peacock A, Tapson VF, Haworth SG, Frost AE, Torbicki A.
`J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):48S-55S. doi: 10.1016/j.jacc.2004.02.010.
`PMID: 15194178 Free article. Review.
`
`4 Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial
`hypertension: a double-blind, randomized, placebo-controlled trial.
`Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ; Treprostinil Study Group.
`Am J Respir Crit Care Med. 2002 Mar 15;165(6):800-4. doi: 10.1164/ajrccm.165.6.2106079.
`PMID: 11897647 Clinical Trial.
`
`5 Prostanoids for pulmonary arterial hypertension.
`Galiè N, Manes A, Branzi A.
`Am J Respir Med. 2003;2(2):123-37. doi: 10.1007/BF03256644.
`PMID: 14720012 Review.
`
`6 Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties.
`Ulrich S, Fischler M, Speich R, Popov V, Maggiorini M.
`Chest. 2006 Sep;130(3):841-6. doi: 10.1378/chest.130.3.841.
`PMID: 16963684 Clinical Trial.
`
`7 Exercise testing in pulmonary arterial hypertension and in chronic heart failure.
`Deboeck G, Niset G, Lamotte M, Vachiéry JL, Naeije R.
`Eur Respir J. 2004 May;23(5):747-51. doi: 10.1183/09031936.04.00111904.
`PMID: 15176691 Free article. Clinical Trial.
`
`8 Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial
`hypertension.
`Shen J, He B, Wang B.
`Chest. 2005 Aug;128(2):714-9. doi: 10.1378/chest.128.2.714.
`PMID: 16100159 Clinical Trial.
`
`9 Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and
`pulmonary arterial hypertension.
`Melian EB, Goa KL.
`Drugs. 2002;62(1):107-33. doi: 10.2165/00003495-200262010-00005.
`PMID: 11790158 Review.
`
`10 Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
`Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS.
`Respir Med. 2005 Dec;99(12):1501-10. doi: 10.1016/j.rmed.2005.03.026.
`
`Liquidia's Exhibit 1118
`Page 2
`
`

`

`PMID: 15890512 Free article. Clinical Trial.
`
`First
`
`Prev
`
`Page 1 of
`12 Next
`
`Last
`
`FOLLOW NCBI
`
`Connect with NLM
`
`
`
`
`
`National Library of Medicine
`8600 Rockville Pike
`Bethesda, MD 20894
`Web Policies
`FOIA
`Help
`Accessibility
`Careers
`NLM NIH HHS USA.gov
`
`Liquidia's Exhibit 1118
`Page 3
`
`

`

`
`Advanced Search
`Enter search terms in at least one of the fields below
`
`Search Index: (1) Keyword:
`
`Search Index: (2) Title:
`
`Search Index: (3) Author:
`
`Popular Limits (optional)
` Open Access
`
`
`
`Narrow your search (optional)
`
`Year
`Return only items published from
`
`Audience
`Return only items for the audience
`Content
`Return only items with the content
`Format
`Return only items in the format
`Language
`Return only items in the language
`
`
`
`Enter search terms: (1) “pulmonary arterial hypertension” + “clinical trial”
`
`Search Clear
`
`Enter search terms: (2)
`
`Enter search terms: (3)
`
`1971
`e.g. 1971
`
`to: 2006
`e.g. 1977
`
`Any Audience
`
`Any Content
`
`All Formats
`
`All Languages
`
`Search Clear
`
`Liquidia's Exhibit 1118
`Page 4
`
`

`

`Search WorldCat
`kw:"pulmonary arterial hype
`Search
`
`Advanced Search Find a Library
`Search results for 'kw:"pulmonary arterial hypertension" AND "clinical trial"' > '1971..2006'
`
`Results 1-10 of about 143 (.11 seconds)
`
`First Prev 1 2 3 Next
`
`Select All Clear All
`
`Save to: [New List]
`
` Save
`
`Sort by: Relevance
`
` Save Search
`
`764632302
`
`1A
`
`mbrisentan therapy for pulmonary arterial hypertension.
`by Galie, Nazzareno; Badesch, David B.; Oudiz, Ronald J.; Simonneau, Gerald;
`McGoon, Michael; Keogh, Anne; Frost, Adaani; Zwicke, Diane; Naeije, Robert;
`Shapiro, Shelley; Olschewski, Horst; Rubin, Lewis
` Downloadable archival material
`Language: English
`Publisher: 2005-08
`
`764632335
`
`2T
`
`ransitioning from i.v. epoprostenol to subcutaneous treprostinil in
`pulmonary arterial hypertension.
`by Vachiery, Jean-Luc; Hill, Nicholas; Zwicke, Diane; Barst, Robyn J.; Blackburn,
`Shelmer D.; Naeije, Robert
` Downloadable archival material
`Language: English
`Publisher: 2002-05
`
`98208441
`
`3E
`
`nd points and clinical trial designs in pulmonary arterial hypertension -
`Clinical and regulatory perspectives
`by Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila
`G Haworth; Adaani E Frost; Adam Torbicki
` Article
`Language: English
`Publication: Journal of the American College of Cardiology. 43, no. 12, (2004): S48
`Publisher: [New York, N.Y.] : Elsevier Biomedical, [c1983-
`
`4932642183
`
`4E
`
`nd points and clinical trial designs in pulmonary arterial hypertension:
`Clinical and regulatory perspectives
`by Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila
`G Haworth; Adaani E Frost; Adam Torbicki
` Article
`Language: English
`Publication: Journal of the American College of Cardiology: Supplement, v43 n12 (2004-06-16):
`S48-S55
`
`111044573
`
`5E
`
`nd points and clinical trial designs in pulmonary arterial hypertension:
`clinical and regulatory perspectives.
`by MM Hoeper; RJ Oudiz; A Peacock; VF Tapson; SG Haworth; AE Frost; A
`Torbicki
` Article
`Language: English
`Publication: Journal of the American College of Cardiology, 2004 Jun 16; 43(12) Suppl S: 48S-
`55S
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`Open Content
`
` Open Access
`
`Format
`
` All Formats (143)
` Article (140)
` Downloadable archival material
`(2)
` Cassette (1)
`
`Refine Your Search
`
`Author
`Barst Rj (4)
`Galie N (4)
`Ghofrani Ha (3)
`Hoeper Marius M (3)
`Hoeper Mm (3)
`Show more ...
`
`Year
`« All Years
`2006 (33)
`2005 (40)
`2004 (16)
`2003 (13)
`2002 (13)
`Show more ...
`
`Language
`English (129)
`French (5)
`Chinese (2)
`Polish (1)
`
`Liquidia's Exhibit 1118
`Page 5
`
`

`

`4643086970
`
`6E
`
`nd points and clinical trial designs in pulmonary arterial hypertension
`by Marius M Hoeper; Ronald J Oudiz; Andrew Peacock; Victor F Tapson; Sheila
`G Haworth; Adaani E Frost; Adam Torbicki
` Article
`Language: English
`Publication: Journal of the American College of Cardiology, v43 n12 (200406): S48-S55
`
`107544413
`
`7C
`
`ardiopulmonary exercise testing and six-minute walk correlations in
`pulmonary arterial hypertension.
`by RJ Oudiz; RJ Barst; JE Hansen; XG Sun; R Garofano; X Wu; K Wasserman
` Article
`Language: English
`Publication: The American journal of cardiology, 2006 Jan 01; 97(1): 123-6
`
`614767672
`
`8P
`
`ulmonary arterial hypertension
`by Azad Raiesdana; Joseph Loscalzo
` Article
`Language: EN
`Publication: Annals of Medicine, 38, no. 2 (2006): 95-110
`Publisher: Informa Healthcare
`
`7777361610
`
`9M
`
`edical therapeutics for pulmonary arterial hypertension: from basic
`science and clinical trial design to evidence-based medicine
`by Roxana Sulica; Michael Poon
` Article
`Language: English
`Publication: Expert Review of Cardiovascular Therapy, v3 n2 (20050301): 347-360
`
`56826816
`10
`Quiet! hospital zone.
`by Richard C Conti; American College of Cardiology.;
` Audiobook on Cassette : Cassette recording
`Language: English
`Publisher: Bethesda, MD : American College of Cardiology, 2004.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`Results 1-10 of about 143 (.11 seconds)
`
`First Prev 1 2 3 Next
`
`Liquidia's Exhibit 1118
`Page 6
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket